I don't want to pay $3,120 for remdesivir to just potentially reduce my recovery time by 20%.“Outside analysts have concluded that ‘The deal is amazingly good for Gilead’s executives and shareholders and amazingly bad for everyone else—bad for taxpayers, terrible for public health, and unethical,’” the lawmakers wrote in the later dated Thursday.
Gilead said it would sell remdesivir for $520 per vial in the U.S. to patients with private insurance and $390 per vial to federal insurance programs like Medicare as well as foreign countries. The majority of patients treated with remdesivir receive a five-day treatment course using six vials of remdesivir, the company said. That would bring the cost to $2,340 for foreign and U.S. Medicare patients and $3,120 for U.S. patients with private health coverage.
That means Gilead is charging “American health insurers the highest prices in the world,” the senators wrote.
Everything in their power to secure access to life-saving therapeutics for the american people. Ok. Hopefully they'll get good news on a new upstart drug in the next couple of weeks.When HHS Secretary Alex Azar announced the agreement last month, he called it “an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19. To the extent possible, we want to ensure that any American patient who needs remdesivir can get it.”
He said the administration “is doing everything in our power to learn more about life-saving therapeutics for COVID-19 and secure access to these options for the American people.”
I am considering itToday seems to be repeating yesterday's midday sideways movement for CYDY. If there isn't a lunchtime short attack, there is probably a good chance the stock rises over the last 90 minutes again today. It could be a savvy day trade.
Agreed, why I said "presumed" plus the volume greatly picked up all at once at a time of day that's usually pretty darn quiet.I'm pretty sure every time a stock goes down, it isn't necessarily a short attack
But that did look like one to bring it down to to 5.06I'm pretty sure every time a stock goes down, it isn't necessarily a short attack
This is the way to do it. The correct process, if you will. Some of the others may still get a great result if CYDY goes to the moon, but the process should be to take the 5-bagger or 10-bagger when you can.Confessional time: I just sold 40% of $CYDY, but it’s not really as bad as that statement reads. I had whatever amount invested That I felt comfortable with. When it dropped to $2.90 I doubled down plus a smidge.
had a good look at the big picture this morning and came to the conclusion if we get some bad news I’d really really hate myself for being overexposed.
im back to the “nice sized but not obscene” amount invested and increased the amount of shares as my price per share dropped. that’s a good thing.
im going to sleep at night either way. When this goes to $50 I’ll still be rich.
Everybody’s guard is up after last week or whenever the big strike was. I’m ready to buy more so bring it on IDGAFBut that did look like one to bring it down to to 5.06
I like the company long term but I think I probably bought at the high for the next several years, lol.FSLY, wait!
Just an update that I've been very happy with this investment so far. ANGL is up around 2% since I bought in. I got in just after the last dividend, but am looking forward to the juicy monthly dividends coming up. Yield is around 5.72%. Just a heads up if anyone is looking for a good dividend paying ETF. Seems to me to be a nice risk/reward addition to a well balanced portfolio.Thanks. I’ve done my research and am going to invest heavily into the ETF named ANGL. It has a dividend yield of 5.72%. It’s comprised of “Fallen Angel” bonds that have been recently downgraded from investor grade to junk grade. Core holdings are companies like Sprint, Kraft Heinz, Newell Brands, Freeport McMoran, etc. Companies that yes have had some tough times but I don’t see them defaulting and vanishing overnight. This seems like free 5+% profit. As old bonds mature, they add select new “angel” items.![]()
![]()
![]()
![]()
![]()
chet chet chet
Thanks for your thoughts. I don't think they wanted to exclude people with those co-morbidities because those patients have such incredibly strong anecdotal data from the EINDs.What they weren't able to do is exclude people based on comorbidities such as diabetes or heart disease, because that would probably knock out too many of their actual severe patient population.
Mark your calendars, and get your notepads and pens out for another knowledge dropping session. Dr. Bruce Patterson will be joining me on the Dr. Yo show week of July 27th. I will confirm time and date sometime next week.
Took my 2% profit and called today a success. Went heavier in LVGO than SE anyway.Bought some more Sea limited this morning, up a little now.
With Fidelity rules, I'll need to hold a few days. Don't know if I'd sell anyway.
Guess they’ll either be talking about good news or what went wrong.
Yeah, that can actually become quite a positive for them as well. If you have broader inclusion and narrower exclusion criteria, then that means you are willing to take on riskier sub-populations within an already risky group. Then if you show that mortality benefit in that scenario it helps wipe away more questions that could remain. I didn't mean the comment as a critique in any way, but upon re-reading could see that maybe could be interpreted that way. They need those populations in there from a practical (enrollment) standpoint as well as aspirational (proof of efficacy) one.Thanks for your thoughts. I don't think they wanted to exclude people with those co-morbidities because those patients have such incredibly strong anecdotal data from the EINDs.
I put in a limit buy at $4.20 just in case it drops that far. Puff, puff, pass.Trimmed some LVGO that bounced nicely for $99.xx to $103.40. Keep half of the new shares looking for a higher exit.
Sold 90% of my pre-market BCQ addition for a 1-1.5% gain. It didn't move the way I expected so taking that profit. I'm still holding my long term shares.
cydy limit orders at $5.25 and $5.15 tripped. Missed on the $5.05 (that seems to be a theme with this stock so I will set them at .x6 going forward. I had them in place at 10 cent increments all the way down to $4.45. This seems to be the only way to pick up cheap shares as the drops are swift and rebounds immediate.
You’ll be fine. My cost basis is $17 so I’m good but I think earnings in a few weeks will be solid.I like the company long term but I think I probably bought at the high for the next several years, lol.
Atleast the shorts are funny sometimes. The longs are just pathetic.You guys read any of the #### on investor boards about Cytodyn?
That kind of #### makes me want to sell so bad. The majority of the people who are long there, they're the dumbest mother####ers on Earth with the #### they write. It frightens me being on the same side as some of them.
Devil's Advocatel; there are some equally stupid shorts.
It doesn't reflect in their stock price bc A) they have nothing new and exciting on the horizon B) everyone knows Remdisivir is useless C) Their HIV franchise only has so much time left, which goes back to A.Thoughts on GILD? I bought over the last month and it's been flat to down. I'm reading all these articles how Trump is filling their coffers with money, but it's not reflecting in the stock price. Hold or Sell?
Probably the same peopleAtleast the shorts are funny sometimes. The longs are just pathetic.
I’d love to see it drop more to add to my 100 shares. I should have just bought in the 20s. Still a tiny bit annoyed I didn’t go all in back in March. Let the fear of another drop cloud the easy decision just based on price.LVGO now in the double digit price.
Incredibly bad. 95% of posts from either side are ridiculous. Some decent ones sprinkled in among the absurd.You guys read any of the #### on investor boards about Cytodyn?
That kind of #### makes me want to sell so bad. The majority of the people who are long there, they're the dumbest mother####ers on Earth with the #### they write. It frightens me being on the same side as some of them.
Devil's Advocatel; there are some equally stupid shorts.
I didn't get started until the 70-80s. Been trading shares to essentially reduce the basis of my initial buys by about $20 to date. I'm still sitting on 20-25% cash waiting for better buying days. Anyway, great tip on your part....thanks.I’d love to see it drop more to add to my 100 shares. I should have just bought in the 20s. Still a tiny bit annoyed I didn’t go all in back in March. Let the fear of another drop cloud the easy decision just based on price.
I’d love to add some more in the 70/80s but that would likely mean a real bad dip overall. Probably should have just bought a large share at $59. I think it’ll be huge long term.
On the yahoo board there is literally one guy whose posts I seek out. Somebody named “thoughtful investor” and this time the username really checks out. Rest of that board is a hellhole.You guys read any of the #### on investor boards about Cytodyn?
That kind of #### makes me want to sell so bad. The majority of the people who are long there, they're the dumbest mother####ers on Earth with the #### they write. It frightens me being on the same side as some of them.
Devil's Advocatel; there are some equally stupid shorts.
What's the likelihood trading indications in advance will be able to tip us off on the results?Think they'll announce they unblinded the results over the weekend, my guess. Maybe overnight tonight, but I'm doubtful... Hopefully they don't #### this up somehow. Results next Friday, possibly over next weekend. Going to be a wild week.
investorhangout the best imo. not to be mistaken with investorhub which is a bit more spammyOn the yahoo board there is literally one guy whose posts I seek out. Somebody named “thoughtful investor” and this time the username really checks out. Rest of that board is a hellhole.
Is 90 how many they have enrolled in that study so far? Saw they are looking for 390 total.There was some discussion last night as to how good the CYDY severe-critical study has to be to be statistically significant.
Here's a link to a calculator.
Not sure I did this correctly, but I used a trial size of 90 with 12 deaths in both placebo and drug arms which translated into the following inputs:
Hypothesized Parameter 0
First Sample Size 30
First sample proportion 0.6
Second Sample Size 60
Second Sample Proportion 0.8
This results in a p-value of 0.0264 which makes it lower than 0.05 and significant.
Love to see Blue Horseshoe, but don't think that'll happen.What's the likelihood trading indications in advance will be able to tip us off on the results?
IIRC, I believe they had enrolled around 130ish-140ishIs 90 how many they have enrolled in that study so far? Saw they are looking for 390 total.
There are more enrolled but I don't know how many they are planning to submit for a safety check.Is 90 how many they have enrolled in that study so far? Saw they are looking for 390 total.
Where would that come from when they are supposed to announce in August?This popped up in news on Thinkorswim, I assumed it came out today -
Penn National Gaming (NASDAQENN) reported Q1 sales of $1.12 billion but lost a total of $608.60 million in terms of earnings, which is a 187.33% decrease from last quarter. Penn National Gaming reached earnings of $696.90 million and sales of $1.34 billion in Q4.
What Is Return On Capital Employed?
Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed in a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth in a company and is a sign of higher earnings per share for shareholders in the future. A low or negative ROCE suggests the opposite.
In Q1, Penn National Gaming posted a ROCE of -0.33%.
And out for another 1.5% gain in 22 minutes.Back in for a another day trade dip in BZQ. Seems to be lagging our markets today.
It will be tonight or tomorrow after the bell.Think they'll announce they unblinded the results over the weekend, my guess. Maybe overnight tonight, but I'm doubtful... Hopefully they don't #### this up somehow. Results next Friday, possibly over next weekend. Going to be a wild week.
Y’all were warnedFSLY downgraded to a sell by Citigroup. Motley Fool puts it at a crossroad in a couple different areas. Anyone concerned?